paradigm shift in drug discovery: discover small molecule degraders using e3scan technology platform
Published 3 years ago • 4.2K plays • Length 45:51Download video MP4
Download video MP3
Similar videos
-
37:35
next-generation drug discovery: leveraging e3 ligases for targeted protein degradation
-
25:02
eurofins discovery case study: understanding tpd complexity using biomap® human phenotypic platform
-
24:20
leveraging the e3scantm technology platform for next-generation targeted protein degradation
-
17:46
recent trends in kinase drug discovery
-
1:05:12
eurofins discovery services
-
55:18
eurofins integrated drug discovery webinar
-
53:24
versatile hit-finding strategies for successful drug discovery programs
-
18:16
phenotypic services center of excellence
-
39:11
biophysics in kinase drug discovery: fbs to protac® ternary complex characterisation
-
48:32
hit discovery for gpcrs: hts or virtual screens?
-
0:43
eurofins discovery idd highlights
-
52:45
global anticancer drug discovery & development trends
-
0:42
small molecule drug discovery primer 201
-
2:01
eurofins discovery: we know what it takes
-
59:41
challenges of implementing innovation in drug discovery and development
-
23:09
eurofins discoverx custom capabilites
-
17:06
eurofins discovery biomap services overview